Results 241 to 250 of about 892,778 (286)

The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity

Molecular Oncology, EarlyView.
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli, Alessio Bevilacqua, Mathias Wenes, Denis Migliorini, Lars van der Veen, Sigrid S Skånland, Giusy Di Conza, Kjetil Taskén   +7 more
wiley   +1 more source

Lanthanide Nanotheranostics in Radiotherapy. [PDF]

Int J Mol Sci
Han S, Liu Y, Cai T, Liu Y, Ge-Zhang S.
europepmc   +1 more source

Targeting p38α in cancer: challenges, opportunities, and emerging strategies

Molecular Oncology, EarlyView.
p38α normally regulates cellular stress responses and homeostasis and suppresses malignant transformation. In cancer, however, p38α is co‐opted to drive context‐dependent proliferation and dissemination. p38α also supports key functions in cells of the tumor microenvironment, including fibroblasts, myeloid cells, and T lymphocytes.
Angel R. Nebreda
wiley   +1 more source

Femoral PEComa Treated With Combined Surgery and Radiotherapy: A Case Report. [PDF]

Clin Case Rep
He Y, Fu K, Xue L, Fan Y, Wu D.
europepmc   +1 more source

Simple radiotherapy techniques

International Journal of Radiation Oncology*Biology*Physics, 1993
openaire   +3 more sources

Risk of cardiovascular-related death after radiotherapy for thoracic cancer. [PDF]

Radiat Oncol
Zhang Z, Yao D, Jiang R, Li N, Xiao W, Zheng Y, Zhou J, Yang Y, Guan T, Liu Z.   +9 more
europepmc   +1 more source

The Evolving Role of Radiation Oncology in the Management of Uterine Cervical Carcinoma: A State-of-the-Art Review for Non-Radiation Oncologists. [PDF]

Life (Basel)
Flores-Balcázar CH, Matsumoto-Palomares SA, Chávez-Zaldívar DI, Marin-Trinidad AI, Castro-Pérez FG, Cetina-Pérez LDC.   +5 more
europepmc   +1 more source

Novel Pt@BSA nanoparticles improve radiotherapeutic outcomes in breast cancer. [PDF]

RSC Med Chem
Zhang Y, Liu Y, Zheng D.
europepmc   +1 more source

Quality of Life and Return to Work After Radiotherapy in Young Adults With Head-and-Neck Cancer-A Bicentric Cross-Sectional Observational Study. [PDF]

Cancer Med
Pannenbecker C, Seidel C, Zou J, Schnell D, Wichmann G, Becker C, Klagges S, Schäfer H, Knopf A, Dietz A, Grosu AL, Mehnert-Theuerkauf A, Nicolay NH, Rühle A.   +13 more
europepmc   +1 more source